申请人:Coleman Paul J.
公开号:US20090105318A1
公开(公告)日:2009-04-23
The present invention is directed to amidoethylthioether compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
本发明涉及一种阻断促进醒觉素受体的酰胺乙基硫醚化合物,该化合物可用于治疗或预防与促进醒觉素受体有关的神经和精神障碍和疾病。本发明还涉及包含这些化合物的制药组合物以及使用这些化合物和组合物预防或治疗与促进醒觉素受体有关的疾病的方法。